Classes
- Statistics for Financial MathematicsNMFM301 | Faculty of Mathematics and Physics
- Foundation of RegressionNMFM334 | Faculty of Mathematics and Physics
- Selected Software Tools for Finance and InsuranceNMFM404 | Faculty of Mathematics and Physics
- Data Science 1NMFP406 | Faculty of Mathematics and Physics
- Probability and Mathematical StatisticsNMSA202 | Faculty of Mathematics and Physics
Publications
- Investment disputes and their explicit role in option market uncertainty and overall risk instability2023 | Faculty of Mathematics and Physics
- CHANGEPOINT ESTIMATION FOR DEPENDENT AND NON-STATIONARY PANELS2020 | Faculty of Mathematics and Physics
- Changepoint in dependent and non-stationary panels2020 | Faculty of Mathematics and Physics
- Implied Volatility Surface Estimation via Quantile Regularization2020 | Faculty of Mathematics and Physics
- Shape Constrained Regression in Sobolev Spaces with Application to Option Pricing2017 | Faculty of Mathematics and Physics
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | Faculty of Mathematics and Physics, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | Faculty of Mathematics and Physics, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science
- Real-time changepoint detection in a nonlinear expectile model2023 | Faculty of Mathematics and Physics
- Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas2022 | Faculty of Mathematics and Physics, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial2022 | Faculty of Mathematics and Physics, First Faculty of Medicine
Loading network view...